USE OF A BENZODIAZEPINE DERIVATIVE AND METHOD OF TREATMENT OF TRAUMATIC BRAIN INJURY

The present invention aims to protect a new use of JM-20, a benzodiazepine derivative, in the treatment of and recovery from traumatic brain injury (TBI) and its related symptoms. Additionally, it provides a method of treatment for TBI-induced brain damage. La présente invention concerne la nouvelle...

Full description

Saved in:
Bibliographic Details
Main Authors NUNEZ FIGUEREDO, YANIER, FARINA GONCALVES, DEBORA, FREIRE ROYES, LUIZ FERNANDO, ALVES COURTES, ALINE, ANTUNES SOARES, FELIX ALEXANDRE, MONDELO RODRIGUEZ, ABEL, PADRON YAQUIS, ALEJANDRO SAUL, DUARTE HARTMANN, DIANE, VIEIRA FURTADO, ANDREZZA BOND, CASSOL, GUSTAVO
Format Patent
LanguageEnglish
French
Published 15.07.2021
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention aims to protect a new use of JM-20, a benzodiazepine derivative, in the treatment of and recovery from traumatic brain injury (TBI) and its related symptoms. Additionally, it provides a method of treatment for TBI-induced brain damage. La présente invention concerne la nouvelle utilisation d'un dérivé de benzodiazépine, composé JM-20, dans le traitement et la récupération du traumatisme crânien et des symptômes associés. L'invention concerne en outre une méthode de traitement de la lésion cérébrale résultante du traumatisme crânien.
Bibliography:Application Number: CA20203164091